Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 3 studies | 16% ± 0% |
Insufficient scRNA-seq data for expression of LMOD3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 21966.60 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 5207.05 | 858 / 861 | 0% | 0 | 0 / 0 |
esophagus | 58% | 140.34 | 838 / 1445 | 2% | 0.04 | 4 / 183 |
spleen | 60% | 62.78 | 144 / 241 | 0% | 0 | 0 / 0 |
lung | 44% | 47.20 | 256 / 578 | 3% | 0.07 | 37 / 1155 |
bladder | 43% | 56.24 | 9 / 21 | 2% | 0.04 | 12 / 504 |
stomach | 29% | 53.04 | 103 / 359 | 9% | 0.15 | 26 / 286 |
blood vessel | 26% | 64.50 | 351 / 1335 | 0% | 0 | 0 / 0 |
prostate | 17% | 64.19 | 42 / 245 | 8% | 0.66 | 38 / 502 |
brain | 16% | 17.96 | 415 / 2642 | 6% | 0.08 | 42 / 705 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.90 | 5 / 45 |
breast | 5% | 13.45 | 21 / 459 | 6% | 0.22 | 66 / 1118 |
intestine | 4% | 3.58 | 37 / 966 | 6% | 0.11 | 34 / 527 |
skin | 1% | 7.72 | 22 / 1809 | 5% | 0.17 | 25 / 472 |
uterus | 1% | 0.49 | 1 / 170 | 6% | 2.12 | 26 / 459 |
adipose | 5% | 6.79 | 58 / 1204 | 0% | 0 | 0 / 0 |
thymus | 4% | 9.41 | 23 / 653 | 1% | 0.07 | 5 / 605 |
peripheral blood | 3% | 9.57 | 30 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 1% | 1.40 | 2 / 258 | 2% | 0.06 | 5 / 230 |
ovary | 2% | 2.19 | 4 / 180 | 0% | 0.01 | 2 / 430 |
kidney | 1% | 0.78 | 1 / 89 | 1% | 0.03 | 9 / 901 |
pancreas | 0% | 0.26 | 1 / 328 | 1% | 0.01 | 1 / 178 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048741 | Biological process | skeletal muscle fiber development |
GO_0006941 | Biological process | striated muscle contraction |
GO_0051694 | Biological process | pointed-end actin filament capping |
GO_0048743 | Biological process | positive regulation of skeletal muscle fiber development |
GO_0006936 | Biological process | muscle contraction |
GO_0045010 | Biological process | actin nucleation |
GO_0030239 | Biological process | myofibril assembly |
GO_0007015 | Biological process | actin filament organization |
GO_0030240 | Biological process | skeletal muscle thin filament assembly |
GO_0030016 | Cellular component | myofibril |
GO_0031430 | Cellular component | M band |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005865 | Cellular component | striated muscle thin filament |
GO_0005737 | Cellular component | cytoplasm |
GO_0005523 | Molecular function | tropomyosin binding |
GO_0003785 | Molecular function | actin monomer binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LMOD3 |
Protein name | Leiomodin-3 (Leiomodin, fetal form) |
Synonyms | |
Description | FUNCTION: Essential for the organization of sarcomeric actin thin filaments in skeletal muscle . Increases the rate of actin polymerization . . |
Accessions | Q0VAK6 ENST00000420581.7 [Q0VAK6-1] ENST00000475434.1 [Q0VAK6-1] ENST00000489031.5 [Q0VAK6-1] |